Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-06-13-Speech-3-621-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-06-13"^^xsd:date2
dcterms:Is Part Of	lp_eu:Defective silicone gel breast implants made by French company PIP (debate)2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20120613.33.3-621-000"2
lpv:hasSubsequent	lp_eu:2012-06-13-Speech-3-622-0002
lpv:speaker	lp:Marc Tarabella2
lpv:spokenAs	member; S&D (2009-07-16--2014-06-30)3 member; Delegation to the Parliamentary Assembly of the Union for the Mediterranean (2010-07-07--2014-06-30)3 unknown; Parti Socialiste (2009-07-16--2014-06-30)3 substitute; Delegation for relations with the United States (2009-09-16--2014-06-30)3 substitute; Delegation to the Euro-Latin American Parliamentary Assembly (2009-10-07--2014-06-30)3 member; FEMM (2012-01-19--2014-06-30)3 substitute; IMCO (2012-01-19--2014-06-30)3 member; AGRI (2012-01-19--2014-06-30)3 member; Delegation for relations with the countries of Southeast Asia and the Association of Southeast Asian Nations (ASEAN) (2009-09-16--2014-06-30)3
lpv:translated text	"Madam President, Commissioner, one might question the apparent inertia of the public authorities in this matter. In such a scenario, the victims have the right to expect real accountability and to be offered real solutions. It is true that the actions of the monitoring committee set up by the health authorities are far from being beyond reproach. I also note that the issue of fee surcharges imposed by surgeons who remove defective implants has not really been addressed, which is not acceptable either. Gilles Pargneaux gave us alarming figures for the number of victims of this criminal act perpetrated by PIP. As regards the question I asked you on 13 January, you told me that the inclusion in the legislation on medical products of injected products or implants intended exclusively for aesthetic use was one of the options proposed by the Commission in a public consultation launched in 2008. Commissioner, I should like to know exactly, in the context of the proposed revision of the legislation on medical devices, if you intend to extend the scope of this legislation to the aesthetic products in question. When can we expect to have this legislation?"@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph